AVDL
USDAvadel Pharmaceuticals plc Ordinary Share
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$18.750
고가
$18.780
저가
$18.680
거래량
1.08M
기업 기본 정보
시가총액
1.8B
산업
Drug Manufacturers - Specialty & Generic
국가
Ireland
거래 통계
평균 거래량
2.43M
거래소
NGM
통화
USD
52주 범위
관련 뉴스
UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20
UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals from Buy to Neutral and maintains the price target from $20 to $20.
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals from Outperform to Market Perform and announces $18.5 price target.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20
Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals from Buy to Hold and lowers the price target from $22 to $20.
Needham Downgrades Avadel Pharmaceuticals to Hold
Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals from Buy to Hold.
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all
